Corium is a commercial-stage biopharmaceutical company that is leading the development and commercialization of central nervous system (CNS) healthcare therapies that provide clinicians with important treatment options for patients, their families, and their caregivers.
Corium, Inc. Announces FDA Approval of ADLARITY® (donepezil transdermal system)
